1,3-Butadiene exposure and cardiovascular disease

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 621, Issue 1-2, 2007, Pages 42-49

  Penn, Arthur ^a   Snyder, Carroll A ^b  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b ECS Consulting Inc   (United States)

Author keywords

1,3 butadiene (BD); Atherosclerosis; Environmental tobacco smoke (ETS); Genetic polymorphisms; Inhalation; Xenobiotic metabolizing genes

Indexed keywords

1,3 BUTADIENE; TOBACCO SMOKE;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; ENVIRONMENTAL EXPOSURE; GENETIC POLYMORPHISM; HUMAN; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SMOKING;

ANIMALS; BUTADIENES; CARDIOVASCULAR DISEASES; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; HUMANS; MUTAGENS; NEOPLASMS; POLYMORPHISM, GENETIC;

NICOTIANA TABACUM;

EID: 34447257590     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2006.12.011     Document Type: Article

References (72)

1. 1,3-Butadiene, CAS # 106-99-0. 11th Report on Carcinogens, US Dept. of Health and Human Services, Washington DC, 2004.
2. California Air Resources Board. Proposed identification of 1, 3-butadiene as a toxic air contaminant, Sacramento, California: California Environmental Protection Agency (1991).
3. Ligocki M.P., Fieber J.L., Ball J.C., Pezda S.A., Heuss J.M., Paul R.T., and Wimette H.J. Projected emission trends and exposure issues for 1,3-butadiene. Proceedings of the Annual Meeting of the Air Waste Management Association (1994)
4. U.S. Environmental Protection Agency. Preliminary draft list of categories and subcategories under Section 112 of the Clean Air Act, Federal Register 56 (1991) 28548-28557.
5. Snyder R., and Andrews L.S. Toxic effects of solvents and vapors. In: Klaassen C.D., Amdur M.O., and Doull J. (Eds). Casarett and Doull's Toxicology. The Basic Science of Poisons. fifth ed. (1996), McGraw-Hill Health Professions Division, New York 738
6. Code of Federal Regulations. US Occupational Safety and Health Administration: OSHA 29 CFR 1910.1000.
7. Code of Federal Regulations. US Occupational Safety and Health Administration: OSHA 29 CFR 1910.1051.
8. US Environmental Protection Agency. Health assessment of 1,3-butadiene, Federal Register 67 (October 30, 2002) 66151-66152.
9. International Agency for Research on Cancer. Monographs on the evaluation of the carcinogenic risk of chemicals to humans, vol. 71, 1 (1999) 109-225.
10. Osterman-Golkar S., and Bond J.A. Biomonitoring of 1,3-butadiene and related compounds. Environ. Health Perspect. 104 Suppl. 5 (1996) 907-915
11. Recio L., Steen A.M., Pluta L.J., Meyer K.G., and Saranko C.J. Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms. Chem.-Biol. Interact. 135-136 (2001) 325-341
12. Risk Assessment of Butadiene. European Union risk assessment report, vol. 20, 2002.
13. Sorsa M., Osterman-Golkar S., Peltonen K.K., Saarikoski S.T., and Sram R. Assessment of exposure to butadiene in the process industry. Toxicology 113 (1996) 77-83
14. Zhao C., Vodicka P., Srám R.J., and Hemminki K. Human DNA adducts of 1,3 butadiene, an important environmental carcinogen. Carcinogenesis 21 (2000) 107-111
15. Hayes R.B., Zhang L., Yin S., Swenberg J.A., Xi L., Wiencke J., Bechtold W.E., Yao M., Rothman N., Haas R., O'Neill J.P., Zhang D., Wiemels J., Dosemeci M., Li G., and Smith M.T. Genotoxic markers among butadiene polymer workers in China. Carcinogenesis 21 (2000) 55-62
16. Zhao C., Vodicka P., Srám R.J., and Hemminki K. DNA adducts of 1,3-butadiene in humans: relationships to exposure, GST genotypes, single-strand breaks, and cytogenetic end points. Environ. Mol. Mutagen. 37 (2001) 226-230
17. Tates A.D., Van Dam F.J., de Zwart F.A., Darroudi F., Natarajan A.T., Rossner P., Peterkova K., Peltonen K., Demopoulos N.A., Stephanou G., Vlachodimitropoulos D., and Sram R.J. Biological effect monitoring in industrial workers from the Czech Republic exposed to low levels of butadiene. Toxicology 113 (1996) 91-99
18. Ammenheuser M.M., Bechtold W.E., Abdel-Rahman S.C., Rosenblatt J.I., Hastings-Smith D.A., and Ward Jr. J.B. Assessment of 1,3-butadiene exposure in polymer production workers using HPRT mutations in lymphocytes as a biomarker. Environ. Health Perspect. 109 (2001) 1249-1255
19. Abdel-Rahman S.Z., Ammenheuser M.M., and Ward Jr. J.B. Human sensitivity to 1,3-butadiene: role of microsomal epoxide hydrolase polymorphisms. Carcinogenesis 22 (2001) 415-423
20. Abdel-Rahman S.Z., Ammenheuser M.M., Omiecinski C.J., Wickliffe J.K., Rosenblatt J.I., and Ward Jr. J.B. Variability in human sensitivity to 1,3-butadiene: influence of polymorphisms in the 5′-flanking region of the microsomal epoxide hydrolase gene (EPHX1). Toxicol. Sci. 85 (2005) 624-631
21. Ma H., Wood T.G., Ammenheuser M.M., Rosenblatt J.I., and Ward Jr. J.B. Molecular analysis of hprt mutant lymphocytes from 1, 3-butadiene-exposed workers. Environ. Mol. Mutagen. 36 (2000) 59-71
22. Zhang L., Hayes R.B., Guo W., McHale C.M., Yin S., Wiencke J.K., O'Neill P.J., Rothman N., Li G.L., and Smith M.T. Lack of increased genetic damage in 1,3-butadiene-exposed Chinese workers studied in relation to EPHX1 and GST genotypes. Mutat. Res. 558 (2004) 63-74
23. Fustinoni S., Perbellini L., Soleo L., Manno M., and Foa V. Biological monitoring in occupational exposure to low levels of 1,3-butadiene. Toxicol. Lett. 149 (2004) 353-360
24. Lovreglio P., Bukvic N., Fustinoni S., Ballini A., Drago I., Foa V., Guanti G., and Soleo L. Lack of genotoxic effect in workers exposed to very low doses of 1,3-butadiene. Arch. Toxicol. 80 6 (2006) 378-381
25. Vodicka P., Kumar R., Stetina R., Musak L., Soucek P., Haufroid V., Sasiadek M., Vodickova L., Naccarati A., Sedikova J., Sanyal S., Kuricova M., Brsiak V., Norppa H., Buchancova J., and Hemminki K. Markers of individual susceptibility and DNA repair rate in workers exposed xenobiotics in a tire plant. Environ. Mol. Mutagen. 44 (2004) 283-292
26. Sathiakumar N., Delzell E., Hovinga M., Macaluso M., Julian J.A., Larson R., Cole P., and Muir D.C. Mortality from cancer and other causes of death among synthetic rubber workers. Occupat. Environ. Med. 55 (1998) 230-235
27. Sathiakumar N., Graff J., Macaluso M., Maldonado G., Matthews R., and Delzell E. An updated study of mortality among North American synthetic rubber industry workers. Occupat. Environ. Med. 62 (2005) 822-829
28. Devine B.J. An update on mortality among workers at a 1,3-butadiene facility-preliminary results. Environ. Health Perspect. 86 (1990) 119-128
29. Melnick R., and Huff J. 1,3-butadiene induces cancers in experimental animals at all concentrations from 6.25 to 8000 parts per million. In: Sorsa M., Peltonen K., Vainio H., and Hemminki K. (Eds). Butadiene and Styrene: Assessment of Health Hazards 127 (1993), International Agency for Research on Cancer Scientific Publication 309-322
30. Owen P., Glaister J., Gaunt I., and Pullinger D. Inhalation toxicity studies with 1,3- butadiene, III: 2 year toxicity/carcinogenicity studies in rats. Am. Ind. Hygiene Assoc. J. 48 (1987) 407-413
31. Csanady G., Guengerich F., and Bond J. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Carcinogenesis 13 (1992) 1143-1153
32. Himmelstein M.W., Turner M.J., Asgharian B., and Bond J.A. Concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation. Carcinogenesis 8 (1994) 1479-1486
33. International Agency for Research on Cancer. Monographs on the evaluation of the carcinogenic risk of chemicals to man: cadmium, nickel, some epoxides, miscellaneous industrial chemicals and general consideration on volatile anaesthetics 11 (1976) 1-293.
34. Albertini R., Clewell H., Himmelstein M., Morinello E., Olin S., Preston J., Scarano L., Smith M., Swenberg J., Tice R., and Travis C. The use of non-tumor data in cancer risk assessment: reflections on butadiene, vinyl chloride, and benzene. Regul. Toxicol. Pharmacol. 37 (2003) 105-132
35. Hayes J.D., and Pulford D.J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 30 (1995) 445-600
36. Oesch F. Mammalian epoxide hydrases: inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. Xenobiotica 3 (1973) 305-340
37. Oesch F., and Bentley P. Antibodies against homogeneous epoxide hydratase provide evidence for a single enzyme hydrating styrene oxide and benz(a)pyrene 4,5-oxide. Nature 259 (1976) 53-55
38. Matanoski G.M., Santos-Burgoa C., and Schwartz L. Mortality of a cohort of workers in the styrene-butadiene polymer manufacturing industry. Environ. Health Perspect. 86 (1990) 107-117
39. Devine B.J., and Hartman C.M. Mortality update of butadiene production workers. Toxicology 113 (1996) 169-181
40. Smith C.J., Perfetti T.A., Rumple M.A., Rodgman A., and Doolittle D.J. International Agency for Research on Cancer Group 2A carcinogens reported in cigarette mainstream smoke. Food Chem. Toxicol. 38 (2000) 371-383
41. Brunnemann K.D., Kagan M.R., Cox J.E., and Hoffmann D. Analysis of 1,3-butadiene and other selected gas-phase components in cigarette mainstream and sidestream smoke by gas chromatography-mass selective detection. Carcinogenesis 10 (1990) 1863-1868
42. Dauber D.V. Spontaneous aretriosclerosis in chickens. Arch. Pathol. 38 (1944) 46-51
43. Moss N., and Benditt E. Ultrastructure of spontaneous and experimentally induced arterial lesions: II. The spontaneous plaque in the chicken. Lab. Invest. 23 (1970) 231-245
44. Batastini G., and Penn A. An ultrastructural comparison of carcinogen-associated and spontaneous aortic lesions in the cockerel. Am. J. Pathol. 114 (1983) 403-409
45. Moss N., and Benditt E. Spontaneous and experimentally induced arterial lesions: III. The cholesterol-induced lesions and the effect of a cholesterol and oil diet on the pre-existing spontaneous plaque in the chicken aorta. Lab. Invest. 23 (1970) 521-534
46. Penn A., and Snyder C.A. Inhalation of sidestream cigarette smoke accelerates development of arteriosclerotic plaques. Circulation 88 (1993) 1820-1825
47. Penn A., Chen L.C., and Snyder C.A. Inhalation of steady-state sidestream smoke from one cigarette promotes arteriosclerotic plaque development. Circulation 90 (1994) 1363-1367
48. Zhu B.Q., Sun Y.P., Sievers R.E., Isenberg W.M., Glantz S.A., and Parmley W.W. Passive smoking increases atherosclerosis in cholesterol-fed rabbits. J. Am. Coll. Cardiol. 21 (1993) 225-232
49. Steenland K., Thun M., Lally C., and Heath Jr. C. Environmental tobacco smoke and coronary heart disease in the American Cancer Society CPS-II cohort. Circulation 94 (1996) 622-628
50. -/- mice fed a chow diet. Circulation 110 (2004) 3715-3720
51. Chemical and biological studies on new cigarette prototypes that heat instead of burn tobacco, R.J. Reynolds Tobacco Company, Winston-Salem, NC, 1988.
52. Yang S.K., McCourt D.W., Roller P.P., and Gelboin H.V. Enzymatic conversion of benzo[a]pyrene leading predominantly to the diol-epoxide r-7, t-8-dihydroxy-t-9, 10-oxy-7,8,9,10-tetrahydrobenzo[a]pyrene through a single enantiomer of r-7, t-8-dihydroxy-7, 8-dihydrobenzo[a]pyrene. Proc. Natl. Acad. Sci. USA 73 (1976) 2594-2598
53. Albert R., Vanderlaan M., Burns F., and Nishizumi M. Effect of carcinogens on chicken atherosclerosis. Cancer Res. 37 (1977) 2232-2235
54. Penn A., Batastini G., Solomon J., Burns F., and Albert R. Dose-dependent size increases of aortic lesions following chronic exposure to 7,12 diemthylbenz(a)anthracene (DMBA). Cancer Res. 41 (1981) 588-592
55. Majesky M., Yang H.Y., Benditt E.P., and Juchau M. Carcinogenesis and atherogenesis: differences in monooxygenase inducibility and bioactivation of benzo(a)pyrene in aortic and hepatic tissues of atherosclerosis susceptible versus resistant pigeons. Carcinogenesis 4 (1983) 647-652
56. Penn A., and Snyder C.A. Arteriosclerotic plaque development is 'promoted' by polynuclear aromatic hydrocarbons. Carcinogenesis 92 (1988) 2185-2189
57. Kerzee J.K., and Ramos K.S. Constitutive and inducible expression of Cyplal and Cyplbl in vascular smooth muscle cells: role of the Ahr vHLH/PAS transcription factor. Circulation Res. 89 (2001) 573-582
58. 32P-postlabeling for formation of 3-hydroxybenzo[a]pyrene and benzo[a]pyrene-3,6-quinone as major proximate genotoxic intermediates. J. Pharm. Exp. Ther. 305 (2003) 394-401
59. Moorthy B., Miller K.P., Jiang W., and Ramos K.S. The atherogen 3-methylcholanthrene induces multiple DNA adducts in mouse aortic smooth muscle cells: role of cytochrome P4501B1. Cardiovasc. Res. 53 (2002) 1002-1009
60. Risner C.H. The determination of benzo[a]pyrene in the total particulate matter of cigarette smoke. J. Chromatogr. Sci. 3 (1988) 113-120
61. Forehand J.B., Dooly G.L., and Moldoveanu S.C. Analysis of polycyclic aromatic hydrocarbons, phenols and aromatic amines in particulate phase cigarette smoke using simultaneous distillation and extraction as a sole sample clean-up step. J. Chromatogr. A 898 (2000) 111-124
62. Vayssier-Taussat M., Camilli T., Yolande A., Meplan C., Hainaut P., Polla B.S., and Weksler B. Effects of tobacco smoke and benzo[a]pyrene on human endothelial cell and monocyte stress response. Am. J. Physiol. Heart Circ. Physiol. 280 (2001) H1293-H1300
63. Xu Q. Role of heat shock proteins in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1547-1559
64. Penn A., Keller K., Snyder C., Nadas A., and Chen L.C. The tar fraction of cigarette smoke does not promote arteriosclerotic plaque development. Environ. Health Perspect. 104 (1996) 1108-1113
65. Bi X., Sheng G., Feng Y., Fu J., and Xie J. Gas- and particulate-phase specific tracer and toxic organic compounds in environmental tobacco smoke. Chemosphere 61 (2005) 1512-1522
66. Penn A., and Snyder C.A. 1,3-Butadiene, a vapor phase component of environmental tobacco smoke, accelerates arteriosclerotic plaque development. Circulation 93 (1996) 552-557
67. 2-propanodeoxyguanosine adduct formation in aortic DNA following inhalation of acrolein. Environ. Health Perspect. 109 (2001) 219-224
68. Penn A., Butler J., Snyder C., and Albert R.E. Cigarette smoke and carbon monoxide do not have equivalent effects upon development of arteriosclerotic lesions. Artery 12 (1983) 117-131
69. Yang Z., Lloyd S., Postlethwait E., and Ballinger S. Butadiene exposure mediates oxidative stress and mitochondrial damage. Annu. Meeting Soc. Free Radical Biol. Med. (2004)
70. Salama S.A., Au W.W., Hunter G.C., Sheahan R.G., Badary O.A., Abdel-Naim A.B., and Hamada F.M.A. Polymorphic metabolizing genes and susceptibility to atherosclerosis among cigarette smokers. Environ. Mol. Mutagen. 40 (2002) 153-160
71. Fornage M., Boerwinkle E., Doris P.A., Jacobs D., Liu K., and Wong N.D. Polymorphism of the soluble epoxide hydrolase is associated with coronary artery calcification in African-American subjects, The Coronary Artery Risk Development In Young Adults (CARDIA) Study. Circulation 109 (2004) 335-339
72. Lee C.R., North K.E., Bray M.S., Fornage M., Seubert J.M., Newman J.W., Hammock B.D., Couper D.J., Heiss G., and Zeldin D.C. Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atheroscelrosis Risk in Communities (ARIC) study. Hum. Mol. Genet. 15 (2006) 1640-1649